4//SEC Filing
DAVIS JOHN C. JR 4
Accession 0000899243-20-010847
CIK 0001690585other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:52 PM ET
Size
5.4 KB
Accession
0000899243-20-010847
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-14+50,000→ 50,000 totalExercise: $8.18Exp: 2030-04-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on April 14, 2020.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741287
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:52 PM ET
- Size
- 5.4 KB